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The journeys that hematopoietic cells take to differentiate from long-term stem cells into committed
cells have recently been a topic of debate. In this issue of Cell Stem Cell, Arinobu et al. (2007) and
Pronk et al. (2007) provide new insights into the paths traveled by hematopoietic progenitors.In the bone marrow, multipotent self-re-
newinghematopoieticstemcells (HSCs)
generate a hierarchy of progenitors that
ultimately produce the hematopoietic
cell lineages. During the past two de-
cades, by utilizing cell-surface markers
in combination with functional analysis,
intermediate hematopoietic populations
have been identified, through which the
hematopoietic cells travel to reach their
final destinations. In this issue of Cell
Stem Cell, two studies describe novel
intermediate progenitors that further
define the map of early hematopoiesis.
Hematopoiesis begins with long-
term hematopoietic stem cells (LT-
HSCs) that have the ability to self-
renew during the entire life span of the
organism (Spangrude et al., 1988).
The LT-HSCs develop into short-term
hematopoietic stem cells (ST-HSCs)
that contain limited self-renewal activ-
ity. The ST-HSCs, in turn, differentiate
into multipotent progenitors (MPPs)
that do not have the capacity to self-re-
new but are multipotent. MPPs further
differentiate into progenitors of the
megakaryocyte/erythorid/myeloid cell
fate, named the common myeloid pro-
genitors (CMPs), or alternatively into
progenitors that have the potential to
become lymphoid cells, named com-
mon lymphoidprogenitors (CLPs) (Aka-
shi et al., 2000; Kondo et al., 1997). The
CMPs subsequently segregate into ei-
ther myelomonocytic precursors, also
named the granulocyte/macrophage
progenitors (GMPs) or alternatively
megakaryocyte/erythrocyte progeni-
tors (MEPs).MEPs, in turn, differentiate
into red blood cells and have the ability
to produce platelets (Figure 1A). These
studies have provided important in-
sights into the framework that under-lies early hematopoiesis and have
served as a starting point for further
segregation of the intermediate popu-
lations.
In the fetal liver, similar studies were
undertaken. The fetal liver contains
intermediate progenitors that showed
B, T, and myeloid potential but lacked
the ability to differentiate into erythroid
cells (Kawamoto, 2006; Lu et al., 2002).
This population of cells was named the
common myelo-lymphoid progenitor
compartment (CMLPs). Furthermore,
it was demonstrated that a separate
population of progenitors showed
both myeloid and erythroid potential,
named commonmyeloid and erythroid
progenitors (CMEPs). The CMEP pop-
ulation was proposed to be the fetal
liver equivalent of the CMP compart-
ment in the adult bone marrow (Kawa-
moto, 2006). Thus, a population of
cells has been identified both in the
fetal liver and the adult bone marrow
that shows CMP activity.
Recent studies have indicated that in
the adult bone marrow alternative
paths exist that hematopoietic progen-
itors take prior to commitment. Specif-
ically, it was demonstrated that the
MPP population is not uniformly multi-
potent, because a fraction of the MPP
compartment showed granulocyte/
macrophage and lymphoid potential
(LMPP) potential but appeared to have
lost their ability to differentiate into
megakaryocyte/erythroid progenitor
cells (Figure 1B) (Adolfsson et al.,
2005). More recent observations, how-
ever, have indicated that the LMPP
population showed substantial mega-
karyocyte and erythroid potential
(Forsberg et al., 2006). Thus, these
most recent data indicated that theCell Stem Cell 1CMPs and CLPs still comprise critical
intermediate populations.
How can we reconcile the various
models that describe the developmen-
tal paths hematopoietic progenitors
take prior to becoming fully commit-
ted? In this issue of Cell Stem Cell,
new approaches have been used that
add to the existing map. Pronk et al.
(2007) have utilized new markers,
CD150, Endoglin, and CD41, to isolate
myeloid progenitors and determined
their developmental lineage potential.
Using this approach, they isolated
distinct progenitor populations that
showed a range of granulocyte/mac-
rophage, erythroid, and megakaryo-
cytic potential. The populations were
named Pre MegE, Pre CFU-E, MkP,
Pre GM, and GMP. Functional analysis
of the purified populations showed
that the Pre GM population acts up-
stream of the GMP compartment. Fur-
thermore, the Pre MegE progenitors
gave rise to Pre CFU-E progenitors,
which in turn, were able to produce
CFU-E cells, indicating a hierarchical
progression from Pre MegE to CFU-
E. Pre MegE progenitors also pro-
duced megakaryocyte progenitors
(MkP). These data provide a novel set
of intermediate progenitors and indi-
cate the multiple journeys hemato-
poietic progenitors can take in order
to develop into the granulocyte, mac-
rophage, erythroid, and megakaryo-
cyte cell lineages (Figure 1C).
Two transcription factors have been
identified that regulate critical steps
in early hematopoiesis. These include
GATA-1 and PU.1. GATA-1 acts to reg-
ulate megakaryocyte/erythroid devel-
opment (Fujiwara et al., 1996). PU.1 is
required to promote granulocytes/, October 2007 ª2007 Elsevier Inc. 357
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PreviewsFigure 1. Pathways in Adult Early Hematopoiesis
(A) Map of early adult hematopoiesis as proposed by Kondo et al. (1997) and Akashi et al. (2000).
(B) Map of early adult hematopoiesis as proposed by Adolfsson et al. (2005).
(C) Map of early adult hematopoiesis as proposed by Pronk et al. (2007).
(D) Map of early adult hematopoiesis as proposed by Arinobu et al. (2007).macrophage/lymphoid but not mega-
karyocyte/erythroiddevelopment (Scott
et al., 1994). Utilizing PU.1 and GATA-1
reporter mice, Arinobu et al. (2007)
now have further subdivided early he-
matopoietic progenitors. They found
that, consistent with previous observa-
tions, cells within the MPP population
that express high levels of PU.1 showed
both lymphoid and granulocyte/macro-
phagebut notmegakaryocyte/erythroid
potential (Figure 1D). On the other hand,
cells expressing substantial levels of
GATA-1 developed into CMP progeni-
tors (Figure 1D). Thus, these studies
suggest that macrophages and granu-
locytes can develop from either the
LMPPsorCMPs, reconciling thevarious
maps that underlie early hematopoiesis
(Figure 1). It is, however, possible that
a small fraction of GATA-1 expressing
cells also express PU.1, and it will
be important to demonstrate, using
the appropriate reporter strains, that
the expression patterns of PU.1 and
GATA-1 are indeed fully exclusive.358 Cell Stem Cell 1, October 2007 ª200How do PU.1 and GATA-1 act to
promote GM versus MegE develop-
ment? Whereas PU.1 is expressed in
LT-HSCs, GATA-1 expression is not
detectable. Critical questions now are
how GATA-1 levels are increased in
the MPP compartment and how timing
and dosage of PU.1 and GATA-1
expression promote the GML versus
Meg/E cell fate.
Is this the end of the story? It seems
unlikely. Further fractionation and
characterization of intermediate popu-
lations will likely provide additional
intermediate populations. As pointed
out by others, there are many roads
along cells travel before they become
fully committed. The important issue
is to find the road that is most fre-
quently used.
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